APA (7th ed.) Citation

HM, C., LS, G., C, F., R, P., DM, B., & T, S. (2025). Increased c-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation. Neuropharmacology, 278, 110541. https://doi.org/10.1016/j.neuropharm.2025.110541

Chicago Style (17th ed.) Citation

HM, Collins, Gullino LS, Fuller C, Pinacho R, Bannerman DM, and Sharp T. "Increased C-Fos Immunoreactivity in Anxiety-related Brain Regions Following Paroxetine Discontinuation." Neuropharmacology 278 (2025): 110541. https://doi.org/10.1016/j.neuropharm.2025.110541.

MLA (9th ed.) Citation

HM, Collins, et al. "Increased C-Fos Immunoreactivity in Anxiety-related Brain Regions Following Paroxetine Discontinuation." Neuropharmacology, vol. 278, 2025, p. 110541, https://doi.org/10.1016/j.neuropharm.2025.110541.